A versatile drug delivery system targeting senescent cells
Daniel Muñoz‐Espín(University of Cambridge), Manuel Serrano(Spanish National Cancer Research Centre)
Cited by 314
Related Papers
Galacto‐conjugation of Navitoclax as an efficient strategy to increase senolytic specificity and reduce platelet toxicity
|Aging Cell|2020|269
G6PD protects from oxidative damage and improves healthspan in mice
|Nature Communications|2016|257
Senescence promotes in vivo reprogramming through p16<scp><sup>INK</sup></scp><sup>4a</sup> and <scp>IL</scp>‐6
|Aging Cell|2017|180
Induction of p53-Dependent Senescence by the MDM2 Antagonist Nutlin-3a in Mouse Cells of Fibroblast Origin
|Cancer Research|2007|135
The efficacy of chemotherapy is limited by intratumoral senescent cells expressing PD-L2
|Nature Cancer|2024|94